Phytochemical, toxicological and antimicrobial evaluation of lawsonia inermis extracts against clinical isolates of pathogenic bacteria by Iram Gull et al.
Gull et al. Annals of Clinical Microbiology and Antimicrobials 2013, 12:36
http://www.ann-clinmicrob.com/content/12/1/36RESEARCH Open AccessPhytochemical, toxicological and antimicrobial
evaluation of lawsonia inermis extracts against
clinical isolates of pathogenic bacteria
Iram Gull*, Maria Sohail, Muhammad Shahbaz Aslam and Muhammad Amin AtharAbstract
Background: The emerging resistance of pathogen against the currently available antimicrobial agents demands
the search of new antimicrobial agents. The use of medicinal plants as natural substitute is the paramount area of
research to overwhelm the drug resistance of infectious agents. Scientists have not made enough effort on the
evaluation of safety of medicinal plant yet.
Methods: In the present study antimicrobial activity of Lawsonia inermis is investigated against clinical isolates of
seven bacteria including four Gram negative (Escherichia coli, Salmonella typhi, Klebsiella spp., Shigella sonnei) and
three Gram positive (Bacillus subtilis, Staphylococcus aureus, Staphylococcus epidermidis) using disc diffusion method.
Four types of Lawsonia inermis extracts were prepared using methanol, chloroform, acetone and water as extraction
solvents, while DMSO (Dimethyl sulfoxide) and water as dissolution solvents. The rate and extent of bacterial killing
was estimated by time-kill kinetic assay at 1× MIC of each bacterial isolate. The overall safety of Lawsonia inermis
extracts was assessed in mice.
Results: Lawsonia inermis displayed noteworthy antimicrobial activity against both gram positive and gram
negative bacterial strains used in the study. The minimum value of MIC for different bacterial strains ranged from
2.31 mg/ml to 9.27 mg/ml. At 1x MIC of each bacterial isolate, 3log10 decrease in CFU was recorded after 6 hours of
drug exposure and no growth was observed in almost all tested bacteria after 24 hours of exposure. No sign of
toxidrome were observed during in vivo toxicity evaluation in mice at 300 mg/kg concentration.
Conclusion: In conclusion, the present study provides the scientific rational for medicinal use of Lawsonia inermis.
The use of Lawsonia inermis extracts is of great significance as substitute antimicrobial agent in therapeutics.
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In traditional herbal medicine, plants have been used for
many years [1]. Therefore, plants have attained status of
natural source of new and potent antimicrobial agents
[2]. Medicinal plants are used as ethnomedicine in dif-
ferent countries around the world [3] and are source of
natural products providing unlimited opportunity for
new drugs because of readily available medicinal diver-
sity [4].
Lawsonia Inermis (L. inermis) is a scientific name of a
tall shrub plant commonly known as Henna or Mehndi* Correspondence: iramgull86@yahoo.com
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stated.[5] or mignonette tree [6] belongs to Kingdom: Plantae,
Division: Angiospermae, Class: Dicotyledoneae, Order:
Myrtales, Family: Lythraceae, Genus: Lawsonia, Species:
L. inermis [7]. Henna is a flowering plant, having a
height of 5 meters, natal to subtropical and tropical re-
gions of world including South Asia, Africa, oases of
Sahara Dessert and even in northern regions of
Australia. Leaves of henna plant are entire, opposite,
sub-sessile, oval-shaped and smooth [8]. Leaves have
length of 2–3 cm with 1–2 cm width [5]. Henna shrub is
highly branched and has greyish-brown barks [9].
Main chemical constituents of henna are Lawsone (2-
hydroxynaphthoquinone), mucilage, mannite, gallic acid. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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cosmetic agent for dyeing hair, nails and skin [11].
In traditional medicine, henna plant is used to treat
many diseases like oedema, bronchitis, menstrual dis-
order, rheumatism, hemorrhoids and even in jaundice,
leprosy, pain, spleen enlargement, dysentery and skin
problems [9,12-14]. Henna can also be used as an astrin-
gent and antihemorragic agent and is also known for its
hypotensive, cardio inhibitory and sedative effects [9]. In
addition, henna is reported to show some other proper-
ties including hypoglycemic [15], immunostimulant [16],
hepatoprotective [17], anti-inflammatory [18], tuberculo-
static [19], anti-cancer and antioxidant properties [20].
The present research is designed to determine the
antimicrobial activity of leaves of Lawsonia inermis avail-




Bacterial cultures used in the present study were clinical
isolates collected from the Shaikh Zayed Hospital and
Jinnah Hospital, Lahore, Pakistan. The cultures comprise
of four Gram negative bacterial isolates namely Escheri-
chia coli, Salmonella typhi, Klebsiella spp., Shigella
sonnei and three Gram positive bacterial isolates namely
Bacillus subtilis, Staphylococcus aureus, Staphylococcus
epidermidis.
Maintenance of bacterial cultures
All the bacterial isolates were cultured and maintained
in LB (Luria Bertani) medium (1% Tryptone, 1% sodium
chloride, 0.5% yeast extract) during all the experiments
of the study until mentioned. The bacterial cultures were
refreshed fortnightly.
Plant material
The dried leaves of Lawsonia inermis (Henna) used in
the present study were purchased from the local market
of Lahore, Pakistan.
Preparation of plant extract
To determine the in vitro antimicrobial activity of
Lawsonia inermis, four different types of extracts includ-
ing methanol extract, aqueous extract, chloroform ex-
tract and acetone extract were prepared.
For the preparation of extracts, dried leaves of Henna
were ground to fine powder mechanically in electric
grinder. Powdered leaves (10 g) were added in four flasks
of 100 ml volume and 50ml of each solvent was added
to each flask separately. The flasks were kept in incuba-
tor at 37°C overnight with shaking at 180 rpm. The con-
tents of flask were first filtered through four layers of
muslin cloth and then through Whatman filter paper.The filtrate was evaporated in rotary evaporator at 50°C.
The weight of residues was recorded. DMSO (Dimethyl
sulfoxide) was used to dissolve the residues of methanol,
acetone and chloroform extracts while aqueous extract
residues were dissolved in distilled water at different
concentrations. The resulting extracts were stored at 4°C
for further use in experiments.Inoculum preparation
Before performing antimicrobial activity assay each bac-
terial strain was refreshed in 5 ml of LB broth (pH 7)
separately under sterile conditions. Cultures were incu-
bated in shaking incubator at 160 rpm for 16 hours at
37°C. Each bacterial culture was maintained at the con-
centration of 107 CFU/ml.Antimicrobial sensitivity test using disc diffusion method
The assay of antimicrobial activity of Lawsonia inermis
extracts was performed by Disc diffusion method [21].
Disc impregnated with DMSO were used as control. The
diameter of zones of inhibition formed was measured in
mm (millimeters). The test was performed in triplicate
with each bacterial strain and mean zone of inhibition
was recorded.Determination of minimum inhibitory concentration (MIC)
MIC of four different extracts of Lawsonia inermis was
determined against the test bacterial cultures using the
method described by Natta et al. [22] with slight modifica-
tions. Briefly, starting from highest concentration of each
extract of Lawsonia inermis serial dilution were prepared
ranging from 544–17 mg/ml for methanol extract, 70–
2.18 mg/ml for chloroform extract, 660–20.65 mg/ml for
aqueous extract and 74.2-2.31 mg/ml for acetone extract.
DMSO was used as diluent for all extract except for aque-
ous extract where water was used instead of DMSO. Ster-
ile discs were dipped in different dilutions for 1 min and
placed on LB agar plates seeded with each bacterial cul-
ture separately. The whole experiment was performed
under aseptic conditions. Plates were then incubated at
37°C for 16 hrs. The minimum concentration of each ex-
tract with clear zone of inhibition was considered as MIC.
The zone of inhibition in each case was measured as the
diameter of the clear zone and results were recorded. Each
experiment was performed in triplicate.Phytochemical analysis
The extracts of Lawsonia inermis prepared in the
present study were screened for phytochemicals includ-
ing carbohydrates, cardioglycosides, terpenoids, tannins,
phenolic compounds, proteins and quinones by phyto-
chemical analysis as below [23].
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1 ml of each of four different extracts was taken in test
tubes separately and treated with 5 ml of Fehling’s solu-
tion (Solution A: 34.6 g of copper (II) sulfate pentahy-
drate dissolved in 500 ml distilled water, Solution B: 125 g
of potassium hydroxide and 173 g of potassium sodium
tartrate tetrahydrate dissolved in 500 ml of distilled
water, combine solution A and solution B (1:1) just be-
fore use). The test tubes were placed in boiling water
bath for 5 min. The tubes were observed for appearance
of yellow or red color precipitates indicating the pres-
ence of reducing sugars.Cardioglycosides
5 ml of each of the four extracts was taken in test tubes
separately and treated with 2 ml of glacial acetic acid
having a drop of ferric chloride solution. 1 ml of the
concentrated sulphuric acid was added to each test tube.
Test tubes were observed for the appearance of brown
coloured ring at the interface indicating the presence of
cardioglycosides.Terpenoids
5 ml of each of the four extracts was taken in test tubes
separately and mixed with 2 ml of chloroform. Concen-
trated sulphuric acid was added to form a layer. Test
tubes were observed for the appearance of reddish
brown colour at the interface.Tannins
2 ml of each extract of Lawsonia inermis was mixed with
few drops of 0.1% ferric chloride solution in test tubes
separately. Test tubes were observed for the appearance























Figure 1 Zone of inhibition (mm) of Lawsonia inermis extracts againsPhenolic compounds
1 ml of each extract of Lawsonia inermis was mixed with
4 drops of ethanol and 3 drops of 0.1% ferric chloride
solution in test tube separately. Test tubes were ob-
served for the appearance of red color.
Proteins
1 ml of each extract was taken in test tubes separately.
2 drops of freshly prepared 0.2% ninhydrin reagent (2.5 g
of ninhydrin dissolved in 50 ml n-butyl alcohol on mild
heating and stirring and diluted 500 ml with n-butyl alco-
hol) were added. Test tubes were heated for few minutes.
Test tubes were observed for the appearance of blue
color.
Quinones
Few drops of 1 N sodium hydroxide solution were mixed
with 1 ml of each extract of Lawsonia inermis in test
tubes separately. Test tubes were observed for the ap-
pearance of red colour indicating the presence of
quinones.
Time-Kill kinetic analysis
The rate of bacterial killing was determined using Lawso-
nia inermis extracts with least MIC value for each bacterial
isolate by time-kill kinetic assay as described by Miyasaki
et al. [24] with slight modifications. Briefly, overnight bac-
terial cultures were diluted to the 5 × 105 CFU/mL with LB
broth supplemented with 1× MIC of Lawsonia inermis ex-
tract for each bacterial isolate. The cultures were grown at
37°C with agitation at 160 rpm. The aliquots of cultures
were collected at different time intervals (0 hr, 1 hr, 6 hr,
12 hrs, 24 hrs, 36 hrs and 48 hrs), serially diluted in LB
broth and plated onto LB agar plates. After incubating the
plates at 37°C for 16 hours viable colonies were enumer-
ated. The results were recorded in terms of log10 CFU and
























Figure 2 Minimum inhibitory concentration (MIC) of different extracts of Lawsonia inermis against tested bacterial isolates.
Table 1 Phytochemical analysis of different extracts of
Lawsonia inermis
Extracts of Lawsonia inermis
Methanol Chloroform Acetone Aqueous
Cardioglycosides + + + +
Terpenoids + - + +
Carbohydrates + + + +
Proteins - - - -
Phenols + + + +
Quinones + + + +
Tannins + + + +
(+ Sign indicating presence of compound; - sign indicating absence
of compound).
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The experiments of acute toxicity in animals were per-
formed in the animal house of Institute of Biochemistry
and Biotechnology, University of the Punjab, Lahore,
Pakistan after the approval of departmental ethical com-
mittee. Each of the two groups comprised of 10 male al-
bino mice (weighing 150-200 g) were used to evaluate
the acute toxicity of Lawsonia inermis ethanol extract.
The animals were housed in cages and served with
proper diet according to the international standards.
One group was administered with ethanol extract of
Lawsonia inermis (300 mg/Kg) and other group with
equal volume of vehicle (DMSO) daily through subcuta-
neous route for 2 weeks by subcutaneous injection. The
animals were continuously observed for signs of toxi-
dromes such as aggression, sedation, rising fur, increased
respiration, altered cardiac rate, excitation, convulsion,
stupor, vomiting, etc. or death in first 2 hours and then
after 24 hours.
Statistical analysis
Values are mean of ± standard deviation of three
triplicates.
Results and discussion
Dried leaves of Lawsonia inermis were used to prepare
the extracts as it has been reported that dried prepar-
ation have more concentrated active phytochemical
compounds than fresh plant material [25]. Four different
types of extracts were prepared including methanol ex-
tract, chloroform extract, aqueous extract and acetone
extract. The results revealed that all extracts exhibited
antimicrobial activity against all bacterial strains used in
the present study. However bacterial strains showed dif-
ferential sensitivity for each extract (Figure 1). Antimicro-
bial activity was not observed with controls (DMSO andwater). According to the study of Papageorgiou et al. [26],
phytochemical constituents of Lawsonia inermis exhibit
antimicrobial activity only against gram positive bacteria
while ineffective for gram negative bacteria. In our study,
it was interested to note that Lawsonia inermis had anti-
microbial activity against both gram positive (S. aureus, B.
subtilis and S. epidermidis) and gram negative (E. coli, S.
typhi, Klebsiella spp. and Shigella) bacteria. The studies of
Bhuwaneshwari et al. [13]; Habbal et al. [27] and Hussain
et al. [28] support our findings.
The values of MIC for each tested bacterial strain had
been shown in Figure 2. From the data in Figure 2, it
was illustrated that all of the tested bacterial isolates
showed minimum value of MIC for chloroform extract
except E. coli and B. subtilis. The minimum MIC value
of E. coli (9.27 mg/ml) and B. subtilis (2.31 mg/ml) was
observed using acetone extract. The MIC values of our
study were less than the MIC values reported by
Al-kurashy et al. [29]. They found MIC values in the range
of 8–64 mg/ml for aqueous extract and 32–64 mg/ml for

























Figure 3 Time-Kill kinetic analysis of tested bacterial isolates.
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lished that chloroform extract of Lawsonia inermis
was more promising antimicrobial agent for S. aureus,
S. epidermidis, S. typhi, Klebsiella spp. and Shigella
while its acetone extract for E. coli and B. subtilis at
least in in vitro antimicrobial assay.
The secondary metabolites mainly attribute the anti-
microbial activity of plants [30]. The active constituents
of these secondary metabolites include phenolic com-
pounds and tannins [31]. In order to identify the metab-
olites present in different extracts of Lawsonia inermis
phytochemical analysis were performed. The data in
Table 1 depicted that methanol, acetone and aqueous ex-
tracts had cardioglycosides, terpenoids, carbohydrates,
phenols, quinones and tannins. While proteins were
absent in all three of these extracts. The chloroform
extract had cardioglycosides, carbohydrates, phenols,
quinones and tannins while proteins and terpenoids
were absent. These metabolites solubilized in solvent on
the bases for polarity. In most of the plant materials,
water soluble components includes starches, tannins, sa-
ponins, polypeptides, terpenoids, lectins and different
ions [32], while alcoholic extract includes flavonol, alkaloids,
tannins, sterols polyphenols etc. [33]. Main chemical con-
stituents of henna include Lawsone (2-hydroxynaphthoqui-
none), mucilage, mannite, gallic acid and tannic acid [10].
The rate of bacterial killing after exposure to the 1×
MIC of respective extract of Lawsonia inermis for each
isolate is summarized in Figure 3. The time required to
achieve 3log10 decrease in CFU is an acceptable index of
bactericidal activity from time-kill analysis [34]. The re-
sults illustrated that not a single bacterial isolate showed
significant bactericidal activity in first hour. Whereas,
3log10 reduction in viability of all tested bacterial isolates
was observed after 12 hours of exposure. The log10 CFU
of all bacterial isolates was reduced to zero after 24hours of exposure except S. epidermidis (36 hours) and
B. subtilis (48 hours).
About 25% of all medicines available in the market
have been derived directly or indirectly from plants
[35,36]. Herbal medicines are generally believed as safe.
However, it is important to evaluate their biological
safety before use to avoid fatal consequences [37]. There
is no doubt in pharmacological properties of Lawsonia
inermis but its toxicological assessment is also indis-
pensable. In vivo acute toxicity of Lawsonia inermis ex-
tracts was checked in mice. No mortality was observed
during the study. All the signs of toxidrome were
negative.
In conclusion, the present study provides the scientific
rational for medicinal use of Lawsonia inermis. The use
of Lawsonia inermis extracts is of great significance as
substitute antimicrobial agent in therapeutics.
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